← Back
$SABS All transactions

SAB Biotherapeutics, Inc.

A

$ Value

$0

Shares

2,400,000

Price

$0

Filed

Aug 28

Insider

Name

Kropotova Alexandra

Title

CHIEF MEDICAL OFFICER

CIK

0001825323

Roles

Officer

Transaction Details

Transaction Date

2025-08-26

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,400,000

Footnotes

Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share ("Common Stock"), pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended (the "Plan"). | The awards are subject to the Company's receipt of stockholder approval to amend the Plan, to increase the number of shares of Common Stock available for issuance thereunder. | The shares of Common Stock underlying the option vest over a four-year period, vesting 1/4 on March 1, 2026, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.

Filing Info

Accession No.

0000950170-25-112047

Form Type

4

Issuer CIK

0001833214

Kropotova Alexandra's History

Date Ticker Type Value
2026-03-24 SABS F
2026-02-03 SABS A $0
2025-12-11 SABS F
2025-11-20 IBIO A $0
2025-09-19 SABS F
2025-08-26 SABS A $0

Other Insiders at SABS (90d)

Insider Bought Sold Last
Reich Samuel J
CEO
2026-02-03
Kropotova Alexandra
CHIEF MEDICAL OFFICER
2026-03-24
Sullivan Eddie Joe
PRESIDENT
2026-02-03
Bausch Christoph Lawrence
CHIEF OPERATING OFFICER
2026-02-03
To Lucy
See Remarks
2026-02-03